Invention Grant
- Patent Title: Stable pharmaceutical formulations of methylnaltrexone
-
Application No.: US14039866Application Date: 2013-09-27
-
Publication No.: US09669096B2Publication Date: 2017-06-06
- Inventor: Suketu P. Sanghvi , Thomas A. Boyd
- Applicant: Progenics Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Progenics Pharmaceuticals, Inc.
- Current Assignee: Progenics Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: McCarter & English, LLP
- Agent Jonathan M. Sparks; Maneesh Gulati
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61K47/02 ; A61K9/00 ; A61K9/19 ; A61K31/047 ; A61K31/195 ; A61K45/06 ; A61K47/12 ; A61K47/18
Abstract:
Stable pharmaceutical compositions useful for administering methylnaltrexone are described, as are methods for making the same. Kits, including these pharmaceutical compositions, also are provided.
Public/Granted literature
- US20140235664A1 STABLE PHARMACEUTICAL FORMULATIONS OF METHYLNALTREXONE Public/Granted day:2014-08-21
Information query
IPC分类:
